FDA Accepts Submission of New Drug BREXAFEMME That Prevents Vaginal Yeast Infections
SCYNEXIS has announced that the FDA has accepted the submission for their ibrexafungerp tablets BREXAFEMME. SCYNEXIS’s submission has been granted…
Clinical Topics
Assessment and management of vaginal bleeding in early pregnancy
Faculty: Antay L. Parker, DNP, APRN, WHNP-BC, CNM, CRNFA, C-EFM, is Assistant Professor of Nursing at East Texas Baptist University…
WHNPs as Partners in Addressing the Maternal Health Crisis
There is a well-recognized maternal health crisis in the United States. In 2020, 861 women* died of pregnancy-related complications. This…
Clinical Topics: Reproductive and Sexual Health
Dr. Laurie L. Ray, assistant professor (clinical track) at Emory University, Nell Hodgson Woodruff School of Nursing, in Atlanta, Georgia…
FDA approves Pfizer and Myovant’s Endometriosis Drug Myfembree After Delay
After a delay, the United States Food and Drug Administration has approved the Pfizer and Myovant drug Myfembree. Myfembree is…